Inventiva S.A. (EPA:IVA)
France · Delayed Price · Currency is EUR 4.645
-0.105 (-2.21%)
Apr 1, 2026, 11:23 AM CET
Inventiva Market Cap
Inventiva has a market cap or net worth of €907.4 million as of April 1, 2026. Its market cap has increased by 243.68% in one year.
Market Cap
907.40M
Enterprise Value
917.69M
Revenue
7.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.65
Market Cap Chart
Since February 15, 2017, Inventiva's market cap has increased from 134.55M to 907.40M, an increase of 574.42%. That is a compound annual growth rate of 23.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 916.95M | 21.67% |
| Dec 31, 2025 | 753.62M | 261.37% |
| Dec 31, 2024 | 208.54M | -1.39% |
| Dec 29, 2023 | 211.49M | 12.21% |
| Dec 30, 2022 | 188.49M | -60.71% |
| Dec 31, 2021 | 479.69M | 6.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 7.41B |
| Nanobiotix | 1.31B |
| DBV Technologies | 979.39M |
| MedinCell | 793.48M |
| Valneva SE | 485.47M |
| Genfit | 413.55M |
| Sensorion | 208.46M |
| Transgene | 204.82M |